How many email patterns does Azora Therapeutics use?

Azora Therapeutics uses 2 known email patterns.

What domain does Azora Therapeutics use for work emails?

Azora Therapeutics uses azoratherapeutics.com for work email addresses.

Most Common Email Formats at Azora Therapeutics

Azora Therapeutics's most common email format is First@azoratherapeutics.com (ex. John@azoratherapeutics.com), used for 80% of azoratherapeutics.com addresses. Azora Therapeutics uses 2 email patterns.

@azoratherapeutics.com

2 patterns

Format	Example	Share of azoratherapeutics.com
First@azoratherapeutics.comMost common	John@azoratherapeutics.com	80%
FLast@azoratherapeutics.com	JDoe@azoratherapeutics.com	20%

Need a specific person's email?

Browse Azora Therapeutics's employee directory (about 2 employees) and reveal verified emails free.

Frequently Asked Questions

What does Azora Therapeutics do?

Azora Therapeutics was founded in 2018 and operates in the Pharmaceutical Manufacturing industry, alongside similar companies like Apellis Pharmaceuticals, Roche and sanofi. You can visit azoratherapeutics.com. Explore Azora Therapeutics's company overview page for more information.

What is Azora Therapeutics's email address format?

Azora Therapeutics's email format typically follows the pattern of First@azoratherapeutics.com; this email format is used 80% of the time. Other contacts within LeadIQ's database had email formats such as FLast@azoratherapeutics.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Azora Therapeutics have currently?

Azora Therapeutics has approximately 2 employees as of October 2026. Key team members to contact include Co-Founder & Chief Operating Officer: J. S. and Cofounder And Ceo: M. D. For more team information and contact data, explore Azora Therapeutics's employee directory with LeadIQ.

Azora Therapeutics Email Format

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

Azora Therapeutics is a small clinical-stage pharmaceutical company based in Playa Del Rey, California, focused on developing therapies for serious inflammatory diseases. Its work centers on novel treatments for conditions such as hidradenitis suppurativa and ulcerative colitis, with programs aimed at addressing inflammatory pathology. The company operates with a compact team and engages in early-stage therapeutic development within the broader pharmaceutical sector.

In June 2026, Azora Therapeutics was acquired by Adial Pharmaceuticals. Following the acquisition, Adial's lead program is AT177, a colon-targeted aryl hydrocarbon receptor agonist designed to enable localized activation in the colon with limited systemic exposure for ulcerative colitis.

Most common format

First@azoratherapeutics.com

Example: John@azoratherapeutics.com

2 patterns. See all formats

Verify a Azora Therapeutics email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at Azora Therapeutics

@azoratherapeutics.com

Need a specific person's email?

Frequently Asked Questions

What does Azora Therapeutics do?

What is Azora Therapeutics's email address format?

How many employees does Azora Therapeutics have currently?

Azora Therapeutics Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.